Cargando…
Delivery of ENaC siRNA to epithelial cells mediated by a targeted nanocomplex: a therapeutic strategy for cystic fibrosis
The inhibition of ENaC may have therapeutic potential in CF airways by reducing sodium hyperabsorption, restoring lung epithelial surface fluid levels, airway hydration and mucociliary function. The challenge has been to deliver siRNA to the lung with sufficient efficacy for a sustained therapeutic...
Autores principales: | Manunta, Maria D. I., Tagalakis, Aristides D., Attwood, Martin, Aldossary, Ahmad M., Barnes, Josephine L., Munye, Mustafa M., Weng, Alexander, McAnulty, Robin J, Hart, Stephen L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428798/ https://www.ncbi.nlm.nih.gov/pubmed/28386087 http://dx.doi.org/10.1038/s41598-017-00662-2 |
Ejemplares similares
-
Effective silencing of ENaC by siRNA delivered with epithelial-targeted nanocomplexes in human cystic fibrosis cells and in mouse lung
por: Tagalakis, Aristides D, et al.
Publicado: (2018) -
A method for concentrating lipid peptide DNA and siRNA nanocomplexes that retains their structure and transfection efficiency
por: Tagalakis, Aristides D, et al.
Publicado: (2015) -
Development of Targeted siRNA Nanocomplexes to Prevent Fibrosis in Experimental Glaucoma Filtration Surgery
por: Fernando, Owen, et al.
Publicado: (2018) -
Nebulisation of Receptor-Targeted Nanocomplexes for Gene Delivery to the Airway Epithelium
por: Manunta, Maria D. I., et al.
Publicado: (2011) -
Chitosan Nanocomplexes for the Delivery of ENaC Antisense Oligonucleotides to Airway Epithelial Cells
por: Kolonko, A. Katharina, et al.
Publicado: (2020)